Peripheral antinociceptive effects of exogenous and immune cell-derived endomorphins in prolonged inflammatory pain

Journal of Neuroscience

Volumn 26, Issue 16, 2006, Pages 4350-4358

  Labuz, Dominika ^a   Berger, Stephan ^a   Mousa, Shaaban A ^a   Zöllner, Christian ^a   Rittner, Heike L ^a   Shaqura, Mohammed A ^a   Segovia Silvestre, Toni ^a   Przewlocka, Barbara ^b   Stein, Christoph ^a   Machelska, Halina ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Antinociception; Endomorphin; Immune cells; Inflammation; Leukocytes; Pain

Indexed keywords

[DEXTRO ALANINE 2, N METHYLPHENYLALANINE 4, GLYCINE 5 OL]ENKEPHALIN H 3; BETA ENDORPHIN; CORTICOTROPIN RELEASING FACTOR; DELTA OPIATE RECEPTOR ANTAGONIST; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE; ENDOMORPHIN 1; ENDOMORPHIN 2; ENDORPHIN DERIVATIVE; ENKEPHALIN DERIVATIVE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; FREUND ADJUVANT; KAPPA OPIATE RECEPTOR ANTAGONIST; LEUCINE ENKEPHALIN; METENKEPHALIN; MU OPIATE RECEPTOR ANTAGONIST; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; NALTRINDOLE; NALTRINDOLE H 3; NORBINALTORPHIMINE; OPIATE; RADIOLIGAND; UNCLASSIFIED DRUG; ANALGESIC AGENT; OLIGOPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DORSAL ROOT; FLOW CYTOMETRY; HINDLIMB; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE; LIGAND BINDING; MALE; NERVE CELL; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STRESS; SUBCUTANEOUS TISSUE; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; IMMUNOLOGY; METABOLISM; METHODOLOGY; NEUTROPHIL; PAIN ASSESSMENT; PATHOLOGY; TIME; WISTAR RAT;

ANALGESICS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; INFLAMMATION; MALE; NEUTROPHILS; OLIGOPEPTIDES; PAIN; PAIN MEASUREMENT; RATS; RATS, WISTAR; TIME FACTORS;

EID: 33646438844     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4349-05.2006     Document Type: Article

References (53)

1. Antunes Bras J, Becker C, Bourgoin S, Lombard M, Cesselin F, Hamon M, Pohl M (2001) Met-enkephalin is preferentially transported into the peripheral processes of primary afferent fibres in both control and HSV1-driven proenkephalin A overexpressing rats. Neuroscience 103:1073-1083.
2. Bao L, Jin SX, Zhang C, Wang LH, Xu ZZ, Zhang FX, Wang LC, Ning FS, Cai HJ, Guan JS, Xiao HS, Xu ZQ, He C, Hökfelt T, Zhou Z, Zhang X (2003) Activation of delta opioid receptors induces receptor insertion and neuropeptide secretion. Neuron 37:121-133.
3. Brack A, Rittner HL, Machelska H, Shaqura M, Mousa SA, Labuz D, Zollner C, Schafer M, Stein C (2004a) Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression. Pain 108:67-75.
4. Brack A, Rittner HL, Machelska H, Leder K, Mousa SA, Schafer M, Stein C (2004b) Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells. Pain 112:229-238.
5. Buzas B, Cox BM (1997) Quantitative analysis of mu and delta opioid receptor gene expression in rat brain and peripheral ganglia using competitive polymerase chain reaction. Neuroscience 76:479-489.
6. Cabot PJ, Carter L, Gaiddon C, Zhang Q, Schäfer M, Loeffler JP, Stein C (1997) Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats. J Clin Invest 100:142-148.
7. Eliason JL, Hannawa KK, Ailawadi G, Sinha I, Ford JW, Deogracias MP, Roelofs KJ, Woodrum DT, Ennis TL, Henke PK, Stanley JC, Thompson RW, Upchurch Jr GR (2005) Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation 112:232-240.
8. Goldberg IE, Rossi GC, Letchworth SR, Mathis JP, Ryan-Moro J, Leventhal L, Su W, Emmel D, Bolan EA, Pasternak GW (1998) Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. J Pharmacol Exp Ther 286:1007-1013.
9. Han Z, Jiang YH, Wan Y, Wang Y, Chang JK, Han JS (1999) Endomorphin-1 mediates 2 Hz but not 100 Hz electroacupuncture analgesia in the rat. Neurosci Lett 274:75-78.
10. Hermanussen S, Do M, Cabot PJ (2004) Reduction of beta-endorphin- containing immune cells in inflamed paw tissue corresponds with a reduction in immune-derived antinociception: reversible by donor activated lymphocytes. Anesth Analg 98:723-729.
11. Horvath G (2000) Endomorphin-1 and endomorphin-2: pharmacology of the selective endogenous mu-opioid receptor agonists. Pharmacol Ther 88:437-463.
12. Huang C, Wang Y, Chang JK, Han JS (2000) Endomorphin and mu-opioid receptors in mouse brain mediate the analgesic effect induced by 2 Hz but not 100 Hz electroacupuncture stimulation. Neurosci Lett 294:159-162.
13. Jessop DS, Richards LJ, Harbuz MS (2002) Opioid peptides endomorphin-1 and endomorphin-2 in the immune system in humans and in a rodent model of inflammation. Ann NY Acad Sci 966:456-463.
14. Knapp RJ, Sharma SD, Toth G, Duong MT, Fang L, Bogert CL, Weber SJ, Hunt M, Davis TP, Wamsley JK, Hruby VJ, Yamamura HI (1991) D-Pen2,4′-125I-Phe4, D-Pen5]enkephalin: a selective high affinity radioligand for delta opioid receptors with exceptional specific activity. J Pharmacol Exp Ther 258:1077-1083.
15. Leff P, Matus M, Calva JC, Salazar A, Acevedo R, De los Heros P, Gompfh H, Allen C, Peng B, Alagon A, Gamba G, Pintar J, Anton B (2005) Cloning and functional characterization of a novel opioid peptide system for the mu opioid receptor. Presented at the annual International Narcotics Research Conference meeting, Annapolis, MD, July, abstract S48, http://www.inrcworld.org/ 2005meeting/INRC05Prog6_28_05LATE.pdf.
16. Machelska H, Cabot PJ, Mousa SA, Zhang Q, Stein C (1998) Pain control in inflammation governed by selectins. Nat Med 4:1425-1428.
17. Machelska H, Mousa SA, Brack A, Schopohl JK, Rittner HL, Schäfer M, Stein C (2002) Opioid control of inflammatory pain regulated by intercellular adhesion molecule-1. J Neurosci 22:5588-5596.
18. Machelska H, Schopohl JK, Mousa SA, Labuz D, Schäfer M, Stein C (2003) Different mechanisms of intrinsic pain inhibition in early and late inflammation. J Neuroimmunol 141:30-39.
19. Machelska H, Brack A, Mousa SA, Schopohl JK, Rittner HL, Schäfer M, Stein C (2004) Selectins and integrins but not platelet-endothelial cell adhesion molecule-1 regulate opioid inhibition of inflammatory pain. Br J Pharmacol 142:772-780.
20. Makulska-Nowak HE, Gumulka SW, Lipkowski AW, Rawa MA (2001) Effects of endomorphin-2 on arterial blood pressure and pain threshold in spontaneously hypertensive rats and modification of these effects by beta-funaltrexamine and nor-binaltorphimine. Life Sci 69:581-589.
21. Martin-Schild S, Zadina JE, Gerall AA, Vigh S, Kastin AJ (1997) Localization of endomorphin-2-like immunoreactivity in the rat medulla and spinal cord. Peptides 18:1641-1649.
22. Martin-Schild S, Gerall AA, Kastin AJ, Zadina JE (1999) Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J Comp Neurol 405:450-471.
23. Monory K, Bourin MC, Spetea M, Tomboly C, Toth G, Matthes HW, Kieffer BL, Hanoune J, Borsodi A (2000) Specific activation of the mu opioid receptor (MOR) by endomorphin 1 and endomorphin 2. Eur J Neurosci 12:577-584.
24. Mousa SA, Zhang Q, Sitte N, Ji R, Stein C (2001) Beta-endorphin- containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J Neuroimmunol 115:71-78.
25. Mousa SA, Machelska H, Schäfer M, Stein C (2002) Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain. J Neuroimmunol 126:5-15.
26. Mousa SA, Shakibaei M, Sitte N, Schafer M, Stein C (2004) Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology 145:1331-1341.
27. Obara I, Przewlocki R, Przewlocka B (2004) Local peripheral effects of muopioid receptor agonists in neuropathic pain in rats. Neurosci Lett 360:85-89.
28. Ohsawa M, Mizoguchi H, Narita M, Chu M, Nagase H, Tseng LF (2000) Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse. J Pharmacol Exp Ther 294:1106-1111.
29. Ohsawa M, Mizoguchi H, Narita M, Nagase H, Kampine JP, Tseng LF (2001a) Differential antinociception induced by spinally administered endomorphin-1 and endomorphin-2 in the mouse. J Pharmacol Exp Ther 298:592-597.
30. Ohsawa M, Shiraki M, Mizoguchi H, Narita M, Kawai K, Nagase H, Cheng EY, Narita M, Tseng LF (2001b) Release of [Met5]enkephalin from the spinal cord by intraventricularly administered endomorphin-2, but not endomorphin-1 in the anesthetized rat. Neurosci Lett 316:1-4.
31. Pierce TL, Wessendorf MW (2000) Immunocytochemical mapping of endomorphin-2-immunoreactivity in rat brain. J Chem Neuroanat 18:181-207.
32. Przewlocki R, Przewlocka B (2001) Opioids in chronic pain. Eur J Pharmacol 429:79-91.
33. Pühler W, Zöllner C, Brack A, Shaqura MA, Krause H, Schäfer M, Stein C (2004) Rapid upregulation of mu opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction. Neuroscience 129:473-479.
34. Rittner HL, Brack A, Machelska H, Mousa SA, Bauer M, Schäfer M, Stein C (2001) Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. Anesthesiology 95:500-508.
35. Sakurada S, Hayashi T, Yuhki M, Orito T, Zadina JE, Kastin AJ, Fujimura T, Murayama K, Sakurada C, Sakurada T, Narita M, Suzuki T, Tan-no K, Tseng LF (2001) Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse. Eur J Pharmacol 427:203-210.
36. Savov JD, Gavett SH, Brass DM, Costa DL, Schwartz DA (2002) Neutrophils play a critical role in development of LPS-induced airway disease. Am J Physiol Lung Cell Mol Physiol 283:L952-L962.
37. Schäfer M, Carter L, Stein C (1994) Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA 91:4219-4223.
38. Schäfer M, Mousa SA, Zhang Q, Carter L, Stein C (1996) Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc Natl Acad Sci USA 93:6096-6100.
39. Schreff M, Schulz S, Wiborny D, Höllt V (1998) Immunofluorescent identification of endomorphin-2-containing nerve fibers and terminals in the rat brain and spinal cord. NeuroReport 9:1031-1034.
40. Spampinato S, Qasem AR, Calienni M, Murari G, Gentilucci L, Tolomelli A, Cardillo G (2003) Antinociception by a peripherally administered novel endomorphin-1 analogue containing beta-proline. Eur J Pharmacol 469:89-95.
41. Stein C, Millan MJ, Shippenberg TS, Peter K, Herz A (1989) Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J Pharmacol Exp Ther 248:1269-1275.
42. Stein C, Gramsch C, Herz A (1990a) Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and β-endorphin. J Neurosci 10:1292-1298.
43. Stein C, Hassan AHS, Przewlocki R, Gramsch C, Peter K, Herz A (1990b) Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci USA 87:5935-5939.
44. Stein C, Hassan AH, Lehrberger K, Giefing J, Yassouridis A (1993) Local analgesic effect of endogenous opioid peptides. Lancet 342:321-324.
45. Stein C, Pflüger M, Yassouridis A, Hoelzl J, Lehrberger K, Welte C, Hassan AHS (1996) No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J Clin Invest 98:793-799.
46. Stein C, Schäfer M, Machelska H (2003) Attacking pain at its source: new perspectives on opioids. Nat Med 9:1003-1008.
47. Stone LS, Fairbanks CA, Laughlin TM, Nguyen HO, Bushy TM, Wessendorf MW, Wilcox GL (1997) Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2. NeuroReport 8:3131-3135.
48. Tseng LF (2002) The antinociceptive properties of endomorphin-1 and endomorphin-2 in the mouse. Jpn J Pharmacol 89:216-220.
49. Tseng LF, Narita M, Suganuma C, Mizoguchi H, Ohsawa M, Nagase H, Kampine JP (2000) Differential antinociceptive effects of endomorphin-1 and endomorphin-2 in the mouse. J Pharmacol Exp Ther 292:576-583.
50. Wenk HN, Honda CN (1999) Immunohistochemical localization of delta opioid receptors in peripheral tissues. J Comp Neurol 408:567-579.
51. Zadina JE, Hackler L, Ge LJ, Kastin AJ (1997) A potent and selective endogenous agonist for the mu-opiate receptor. Nature 386:499-502.
52. Zhang Q, Schäfer M, Elde R, Stein C (1998) Effects of neurotoxins and hindpaw inflammation on opioid receptor immunoreactivities in dorsal root ganglia. Neuroscience 85:281-291.
53. Zöllner C, Shaqura MA, Bopaiah CP, Mousa S, Stein C, Schäfer M (2003) Painful inflammation-induced increase in micro-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol Pharmacol 64:202-210.